{"count": 5, "results": [{"_id": "34144348", "pmid": 34144348, "pmcid": "PMC8220249", "title": "Simvastatin-romidepsin combination kills bladder cancer cells synergistically", "journal": "Transl Oncol", "authors": ["Okubo K", "Miyai K", "Kato K", "Asano T", "Sato A"], "date": "2021-09-01T00:00:00Z", "doi": "10.1016/j.tranon.2021.101154", "meta_date_publication": "2021 Sep", "meta_volume": "14", "meta_issue": "9", "meta_pages": "101154", "score": 50277.61, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@-@CHEMICAL_romidepsin @CHEMICAL_MESH:C087123 @@@romidepsin@@@ combination kills @<m>DISEASE_Urinary_Bladder_Neoplasms</m> @DISEASE_MESH:D001749 @@@bladder cancer@@@ cells synergistically", "citations": {"NLM": "Okubo K, Miyai K, Kato K, Asano T, Sato A. Simvastatin-romidepsin combination kills bladder cancer cells synergistically Transl Oncol. 2021 Sep;14(9):101154. PMID: 34144348", "BibTeX": "@article{34144348, title={Simvastatin-romidepsin combination kills bladder cancer cells synergistically}, author={Okubo K and Miyai K and Kato K and Asano T and Sato A}, journal={Transl Oncol}, volume={14}, number={9}, pages={101154}}"}}, {"_id": "37773843", "pmid": 37773843, "pmcid": "PMC10545138", "title": "Statins, commonly coprescribed drugs, and concomitant risk factors: A protective, neutral, or harmful association with common cancer types development: A 10-year multicentric retrospective lebanese study", "journal": "Medicine (Baltimore)", "authors": ["Chalhoub IG", "Boulos RT", "Dagher YG", "El Helou S", "Haifa KG", "Atallah B", "Nasr F", "Kassab I", "Chahine MN"], "date": "2023-09-29T00:00:00Z", "doi": "10.1097/MD.0000000000034562", "meta_date_publication": "2023 Sep 29", "meta_volume": "102", "meta_issue": "39", "meta_pages": "e34562", "score": 50255.816, "text_hl": "However, a duration-response relationship was established between @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @DISEASE_Lung_Neoplasms @DISEASE_MESH:D008175 @@@lung cancer@@@ (odds ratio [OR]=1.208) as well as @<m>DISEASE_Urinary_Bladder_Neoplasms</m> @DISEASE_MESH:D001749 @@@bladder cancer@@@ (OR=1.189). ", "citations": {"NLM": "Chalhoub IG, Boulos RT, Dagher YG, El Helou S, Haifa KG, Atallah B, Nasr F, Kassab I, Chahine MN. Statins, commonly coprescribed drugs, and concomitant risk factors: A protective, neutral, or harmful association with common cancer types development: A 10-year multicentric retrospective lebanese study Medicine (Baltimore). 2023 Sep 29;102(39):e34562. PMID: 37773843", "BibTeX": "@article{37773843, title={Statins, commonly coprescribed drugs, and concomitant risk factors: A protective, neutral, or harmful association with common cancer types development: A 10-year multicentric retrospective lebanese study}, author={Chalhoub IG and Boulos RT and Dagher YG and El Helou S and Haifa KG and Atallah B and Nasr F and Kassab I and Chahine MN}, journal={Medicine (Baltimore)}, volume={102}, number={39}, pages={e34562}}"}}, {"_id": "40916434", "pmid": 40916434, "title": "Mevalonate Metabolic Reprogramming Drives Cisplatin Resistance in Bladder Cancer: Mechanisms and Therapeutic Targeting.", "journal": "Protein Pept Lett", "authors": ["Fang Q", "You C", "Xiao X", "Liu Y", "Yang W", "Li Q", "Qing L", "Dong Z"], "date": "2025-09-03T00:00:00Z", "doi": "10.2174/0109298665403178250806111943", "meta_date_publication": "2025 Sep 3", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50249.85, "text_hl": "In vitro, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ inhibited the proliferation of @<m>DISEASE_Urinary_Bladder_Neoplasms</m> @DISEASE_MESH:D001749 @@@bladder cancer@@@ cells and enhanced their sensitivity to @CHEMICAL_Cisplatin @CHEMICAL_MESH:D002945 @@@cisplatin@@@. ", "citations": {"NLM": "Fang Q, You C, Xiao X, Liu Y, Yang W, Li Q, Qing L, Dong Z. Mevalonate Metabolic Reprogramming Drives Cisplatin Resistance in Bladder Cancer: Mechanisms and Therapeutic Targeting. Protein Pept Lett. 2025 Sep 3;():. PMID: 40916434", "BibTeX": "@article{40916434, title={Mevalonate Metabolic Reprogramming Drives Cisplatin Resistance in Bladder Cancer: Mechanisms and Therapeutic Targeting.}, author={Fang Q and You C and Xiao X and Liu Y and Yang W and Li Q and Qing L and Dong Z}, journal={Protein Pept Lett}}"}}, {"_id": "37454211", "pmid": 37454211, "pmcid": "PMC10349853", "title": "PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling", "journal": "Cell Death Dis", "authors": ["Chen H", "Yang W", "Li Y", "Ji Z"], "date": "2023-07-15T00:00:00Z", "doi": "10.1038/s41419-023-05970-2", "meta_date_publication": "2023 Jul 15", "meta_volume": "14", "meta_issue": "7", "meta_pages": "433", "score": 50246.28, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and @CHEMICAL_Verteporfin @CHEMICAL_MESH:D000077362 @@@verteporfin@@@ abrogate @GENE_PLAGL2 @GENE_5326 @@@PLAGL2@@@-mediated @<m>DISEASE_Urinary_Bladder_Neoplasms</m> @DISEASE_MESH:D001749 @@@BCa@@@ progression", "citations": {"NLM": "Chen H, Yang W, Li Y, Ji Z. PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling Cell Death Dis. 2023 Jul 15;14(7):433. PMID: 37454211", "BibTeX": "@article{37454211, title={PLAGL2 promotes bladder cancer progression via RACGAP1/RhoA GTPase/YAP1 signaling}, author={Chen H and Yang W and Li Y and Ji Z}, journal={Cell Death Dis}, volume={14}, number={7}, pages={433}}"}}, {"_id": "27779188", "pmid": 27779188, "pmcid": "PMC5078845", "title": "Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARgamma signalling pathway", "journal": "Sci Rep", "authors": ["Wang G", "Cao R", "Wang Y", "Qian G", "Dan HC", "Jiang W", "Ju L", "Wu M", "Xiao Y", "Wang X"], "date": "2016-10-25T00:00:00Z", "doi": "10.1038/srep35783", "meta_date_publication": "2016 Oct 25", "meta_volume": "6", "meta_issue": "", "meta_pages": "35783", "score": 50058.812, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ induces cell cycle arrest and inhibits proliferation of @<m>DISEASE_Urinary_Bladder_Neoplasms</m> @DISEASE_MESH:D001749 @@@bladder cancer@@@ cells via @GENE_PPARG @GENE_5468 @@@PPARgamma@@@ signalling pathway", "citations": {"NLM": "Wang G, Cao R, Wang Y, Qian G, Dan HC, Jiang W, Ju L, Wu M, Xiao Y, Wang X. Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARgamma signalling pathway Sci Rep. 2016 Oct 25;6():35783. PMID: 27779188", "BibTeX": "@article{27779188, title={Simvastatin induces cell cycle arrest and inhibits proliferation of bladder cancer cells via PPARgamma signalling pathway}, author={Wang G and Cao R and Wang Y and Qian G and Dan HC and Jiang W and Ju L and Wu M and Xiao Y and Wang X}, journal={Sci Rep}, volume={6}, pages={35783}}"}}]}